Interferon alpha-2b - Biolex
Alternative Names: Alfa interferon - Biolex; BLX-883Latest Information Update: 02 Oct 2021
At a glance
- Originator Biolex
- Class Antineoplastics; Antivirals; Interferons; Recombinant proteins
- Mechanism of Action Interferon alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Hepatitis C
Most Recent Events
- 04 Nov 2005 Biolex has completed a phase I trial in USA and the UK
- 25 Feb 2005 Phase-I clinical trials in Cancer in United Kingdom (unspecified route)
- 25 Feb 2005 Phase-I clinical trials in Cancer in USA (unspecified route)